nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS2—bone cancer	0.376	1	CbGaD
Ketoprofen—SLC22A11—Methotrexate—bone cancer	0.0722	0.166	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—bone cancer	0.0688	0.158	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—bone cancer	0.0672	0.155	CbGbCtD
Ketoprofen—PTGS2—Cisplatin—bone cancer	0.0609	0.14	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—bone cancer	0.0482	0.111	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—bone cancer	0.042	0.0967	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—bone cancer	0.0293	0.0674	CbGbCtD
Ketoprofen—ALB—Methotrexate—bone cancer	0.0249	0.0574	CbGbCtD
Ketoprofen—CYP2C9—Cisplatin—bone cancer	0.0207	0.0477	CbGbCtD
Ketoprofen—Mebendazole—TUBB4B—bone cancer	0.00299	0.375	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—bone cancer	0.000437	0.0547	CrCbGaD
Ketoprofen—Carprofen—PTGS2—bone cancer	0.000437	0.0547	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—bone cancer	0.000419	0.0525	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS2—bone cancer	0.000357	0.0446	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—bone cancer	0.000339	0.0425	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS2—bone cancer	0.000332	0.0415	CrCbGaD
Ketoprofen—Mebendazole—CYP3A4—bone cancer	0.000325	0.0406	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—bone cancer	0.000324	0.0406	CrCbGaD
Ketoprofen—Hyponatraemia—Epirubicin—bone cancer	0.000308	0.00279	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000307	0.00278	CcSEcCtD
Ketoprofen—Myalgia—Cisplatin—bone cancer	0.000307	0.00277	CcSEcCtD
Ketoprofen—Anxiety—Cisplatin—bone cancer	0.000306	0.00277	CcSEcCtD
Ketoprofen—Discomfort—Cisplatin—bone cancer	0.000303	0.00274	CcSEcCtD
Ketoprofen—Increased appetite—Doxorubicin—bone cancer	0.000302	0.00274	CcSEcCtD
Ketoprofen—Migraine—Epirubicin—bone cancer	0.000302	0.00274	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000301	0.00273	CcSEcCtD
Ketoprofen—Renal impairment—Doxorubicin—bone cancer	0.000299	0.0027	CcSEcCtD
Ketoprofen—Dermatitis bullous—Doxorubicin—bone cancer	0.000297	0.00269	CcSEcCtD
Ketoprofen—Face oedema—Epirubicin—bone cancer	0.000297	0.00268	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000296	0.00267	CcSEcCtD
Ketoprofen—Purpura—Doxorubicin—bone cancer	0.000295	0.00267	CcSEcCtD
Ketoprofen—Oedema—Cisplatin—bone cancer	0.000294	0.00266	CcSEcCtD
Ketoprofen—Anaphylactic shock—Cisplatin—bone cancer	0.000294	0.00266	CcSEcCtD
Ketoprofen—Infection—Cisplatin—bone cancer	0.000292	0.00264	CcSEcCtD
Ketoprofen—Cardiac failure—Doxorubicin—bone cancer	0.000291	0.00264	CcSEcCtD
Ketoprofen—Thrombocytopenia—Cisplatin—bone cancer	0.000288	0.0026	CcSEcCtD
Ketoprofen—Tachycardia—Cisplatin—bone cancer	0.000287	0.0026	CcSEcCtD
Ketoprofen—Hyponatraemia—Doxorubicin—bone cancer	0.000285	0.00258	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000284	0.00257	CcSEcCtD
Ketoprofen—Hyperhidrosis—Cisplatin—bone cancer	0.000284	0.00257	CcSEcCtD
Ketoprofen—Asthma—Methotrexate—bone cancer	0.000284	0.00257	CcSEcCtD
Ketoprofen—Salsalate—PTGS2—bone cancer	0.000282	0.0353	CrCbGaD
Ketoprofen—Abdominal pain upper—Epirubicin—bone cancer	0.000281	0.00254	CcSEcCtD
Ketoprofen—Anorexia—Cisplatin—bone cancer	0.00028	0.00254	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—bone cancer	0.00028	0.00253	CcSEcCtD
Ketoprofen—Pancreatitis—Methotrexate—bone cancer	0.000278	0.00252	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000277	0.0025	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—bone cancer	0.000274	0.00248	CcSEcCtD
Ketoprofen—Gastritis—Epirubicin—bone cancer	0.000272	0.00246	CcSEcCtD
Ketoprofen—Suprofen—PTGS2—bone cancer	0.00027	0.0338	CrCbGaD
Ketoprofen—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000268	0.00242	CcSEcCtD
Ketoprofen—Asthma—Epirubicin—bone cancer	0.000265	0.0024	CcSEcCtD
Ketoprofen—Paraesthesia—Cisplatin—bone cancer	0.000264	0.00239	CcSEcCtD
Ketoprofen—Dyspnoea—Cisplatin—bone cancer	0.000262	0.00237	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—RGS1—bone cancer	0.000261	0.00368	CbGpPWpGaD
Ketoprofen—Erectile dysfunction—Methotrexate—bone cancer	0.000261	0.00236	CcSEcCtD
Ketoprofen—Pancreatitis—Epirubicin—bone cancer	0.00026	0.00236	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—bone cancer	0.00026	0.00235	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Methotrexate—bone cancer	0.000259	0.00234	CcSEcCtD
Ketoprofen—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000256	0.00361	CbGpPWpGaD
Ketoprofen—CXCL8—Bladder Cancer—TP53—bone cancer	0.000256	0.00361	CbGpPWpGaD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000256	0.00232	CcSEcCtD
Ketoprofen—Decreased appetite—Cisplatin—bone cancer	0.000256	0.00231	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—EZH2—bone cancer	0.000255	0.00359	CbGpPWpGaD
Ketoprofen—Gastrointestinal disorder—Cisplatin—bone cancer	0.000254	0.0023	CcSEcCtD
Ketoprofen—Drowsiness—Methotrexate—bone cancer	0.000253	0.00229	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—bone cancer	0.000251	0.00228	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000251	0.00227	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—GRM1—bone cancer	0.000249	0.00352	CbGpPWpGaD
Ketoprofen—Renal failure—Methotrexate—bone cancer	0.000249	0.00225	CcSEcCtD
Ketoprofen—Stomatitis—Methotrexate—bone cancer	0.000247	0.00223	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—bone cancer	0.000246	0.00222	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—bone cancer	0.000246	0.00222	CcSEcCtD
Ketoprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000244	0.00344	CbGpPWpGaD
Ketoprofen—Sweating—Methotrexate—bone cancer	0.000242	0.00219	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—bone cancer	0.000242	0.00219	CcSEcCtD
Ketoprofen—Feeling abnormal—Cisplatin—bone cancer	0.000242	0.00219	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—bone cancer	0.000242	0.00219	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—bone cancer	0.000241	0.00218	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—bone cancer	0.000241	0.00218	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—PLAU—bone cancer	0.00024	0.00339	CbGpPWpGaD
Ketoprofen—Weight decreased—Epirubicin—bone cancer	0.00024	0.00217	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—bone cancer	0.000239	0.00216	CcSEcCtD
Ketoprofen—SLC22A7—Fluoropyrimidine Activity—TP53—bone cancer	0.000237	0.00334	CbGpPWpGaD
Ketoprofen—Drowsiness—Epirubicin—bone cancer	0.000237	0.00214	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—bone cancer	0.000236	0.00214	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000235	0.00332	CbGpPWpGaD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000235	0.00212	CcSEcCtD
Ketoprofen—Fenoprofen—PTGS2—bone cancer	0.000233	0.0292	CrCbGaD
Ketoprofen—Renal failure—Epirubicin—bone cancer	0.000233	0.00211	CcSEcCtD
Ketoprofen—CXCL8—ATF-2 transcription factor network—JUN—bone cancer	0.000232	0.00327	CbGpPWpGaD
Ketoprofen—Stomatitis—Epirubicin—bone cancer	0.000231	0.00209	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—bone cancer	0.000231	0.00209	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—bone cancer	0.00023	0.00208	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—GRM4—bone cancer	0.00023	0.00324	CbGpPWpGaD
Ketoprofen—Hepatitis—Methotrexate—bone cancer	0.000227	0.00205	CcSEcCtD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDK4—bone cancer	0.000227	0.0032	CbGpPWpGaD
Ketoprofen—Sweating—Epirubicin—bone cancer	0.000227	0.00205	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—GRM1—bone cancer	0.000227	0.00319	CbGpPWpGaD
Ketoprofen—Haematuria—Epirubicin—bone cancer	0.000226	0.00204	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—bone cancer	0.000225	0.00204	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—bone cancer	0.000224	0.00203	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—bone cancer	0.000224	0.00202	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—BRAF—bone cancer	0.000223	0.00315	CbGpPWpGaD
Ketoprofen—Epistaxis—Epirubicin—bone cancer	0.000223	0.00202	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—bone cancer	0.000222	0.00201	CcSEcCtD
Ketoprofen—ALB—Folate Metabolism—DHFR—bone cancer	0.000222	0.00313	CbGpPWpGaD
Ketoprofen—Agranulocytosis—Epirubicin—bone cancer	0.000221	0.002	CcSEcCtD
Ketoprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.00022	0.0031	CbGpPWpGaD
Ketoprofen—Drowsiness—Doxorubicin—bone cancer	0.000219	0.00198	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—bone cancer	0.000219	0.00198	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—JUN—bone cancer	0.000217	0.00306	CbGpPWpGaD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000217	0.00196	CcSEcCtD
Ketoprofen—Hypersensitivity—Cisplatin—bone cancer	0.000217	0.00196	CcSEcCtD
Ketoprofen—Mefenamic acid—PTGS2—bone cancer	0.000216	0.027	CrCbGaD
Ketoprofen—Renal failure—Doxorubicin—bone cancer	0.000215	0.00195	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—bone cancer	0.000215	0.00194	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—bone cancer	0.000213	0.00193	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—bone cancer	0.000213	0.00193	CcSEcCtD
Ketoprofen—Rhinitis—Epirubicin—bone cancer	0.000213	0.00193	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—bone cancer	0.000213	0.00193	CcSEcCtD
Ketoprofen—Hepatitis—Epirubicin—bone cancer	0.000212	0.00192	CcSEcCtD
Ketoprofen—Naproxen—PTGS2—bone cancer	0.000212	0.0265	CrCbGaD
Ketoprofen—Tinnitus—Methotrexate—bone cancer	0.000212	0.00192	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP9—bone cancer	0.000212	0.00298	CbGpPWpGaD
Ketoprofen—Asthenia—Cisplatin—bone cancer	0.000211	0.00191	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—bone cancer	0.000211	0.00191	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—bone cancer	0.00021	0.0019	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—bone cancer	0.000209	0.00189	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—CDK4—bone cancer	0.000207	0.00291	CbGpPWpGaD
Ketoprofen—Epistaxis—Doxorubicin—bone cancer	0.000207	0.00187	CcSEcCtD
Ketoprofen—Phenprocoumon—CYP3A4—bone cancer	0.000205	0.0257	CrCbGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000205	0.00289	CbGpPWpGaD
Ketoprofen—Visual impairment—Epirubicin—bone cancer	0.000205	0.00185	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—bone cancer	0.000204	0.00185	CcSEcCtD
Ketoprofen—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000204	0.00288	CbGpPWpGaD
Ketoprofen—Chills—Methotrexate—bone cancer	0.000204	0.00184	CcSEcCtD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000203	0.00286	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—JUN—bone cancer	0.000202	0.00285	CbGpPWpGaD
Ketoprofen—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000202	0.00284	CbGpPWpGaD
Ketoprofen—Diarrhoea—Cisplatin—bone cancer	0.000201	0.00182	CcSEcCtD
Ketoprofen—Erythema multiforme—Epirubicin—bone cancer	0.000201	0.00182	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—BRAF—bone cancer	0.000201	0.00283	CbGpPWpGaD
Ketoprofen—Alopecia—Methotrexate—bone cancer	0.000201	0.00182	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—GRM1—bone cancer	0.000199	0.00281	CbGpPWpGaD
Ketoprofen—Tinnitus—Epirubicin—bone cancer	0.000198	0.00179	CcSEcCtD
Ketoprofen—Erythema—Methotrexate—bone cancer	0.000198	0.00179	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—RB1—bone cancer	0.000197	0.00278	CbGpPWpGaD
Ketoprofen—Flushing—Epirubicin—bone cancer	0.000197	0.00178	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—bone cancer	0.000197	0.00178	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—MMP9—bone cancer	0.000197	0.00277	CbGpPWpGaD
Ketoprofen—Hepatitis—Doxorubicin—bone cancer	0.000197	0.00178	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—bone cancer	0.000195	0.00177	CcSEcCtD
Ketoprofen—ALB—Platelet degranulation—SPARC—bone cancer	0.000195	0.00274	CbGpPWpGaD
Ketoprofen—Dysgeusia—Methotrexate—bone cancer	0.000194	0.00175	CcSEcCtD
Ketoprofen—CXCL8—Cellular responses to stress—EZH2—bone cancer	0.000192	0.00271	CbGpPWpGaD
Ketoprofen—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	0.000191	0.00269	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000191	0.00269	CbGpPWpGaD
Ketoprofen—Chills—Epirubicin—bone cancer	0.000191	0.00173	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—bone cancer	0.00019	0.00172	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—bone cancer	0.000189	0.00171	CcSEcCtD
Ketoprofen—ABCC4—NRF2 pathway—GSTP1—bone cancer	0.000188	0.00266	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—TGFBR2—bone cancer	0.000188	0.00266	CbGpPWpGaD
Ketoprofen—Alopecia—Epirubicin—bone cancer	0.000188	0.0017	CcSEcCtD
Ketoprofen—Vomiting—Cisplatin—bone cancer	0.000187	0.00169	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—bone cancer	0.000186	0.00168	CcSEcCtD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000185	0.00261	CbGpPWpGaD
Ketoprofen—Rash—Cisplatin—bone cancer	0.000185	0.00168	CcSEcCtD
Ketoprofen—Dermatitis—Cisplatin—bone cancer	0.000185	0.00168	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—bone cancer	0.000185	0.00167	CcSEcCtD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000184	0.00259	CbGpPWpGaD
Ketoprofen—Ill-defined disorder—Methotrexate—bone cancer	0.000183	0.00166	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—bone cancer	0.000183	0.00166	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—bone cancer	0.000183	0.00165	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—bone cancer	0.000182	0.00165	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—bone cancer	0.000182	0.00165	CcSEcCtD
Ketoprofen—Warfarin—CYP3A4—bone cancer	0.000182	0.0228	CrCbGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.000182	0.00256	CbGpPWpGaD
Ketoprofen—Tension—Epirubicin—bone cancer	0.000182	0.00164	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—bone cancer	0.000181	0.00164	CcSEcCtD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.00018	0.00254	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—RB1—bone cancer	0.00018	0.00253	CbGpPWpGaD
Ketoprofen—Nervousness—Epirubicin—bone cancer	0.00018	0.00163	CcSEcCtD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—bone cancer	0.000179	0.00253	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—JUN—bone cancer	0.000178	0.00251	CbGpPWpGaD
Ketoprofen—Malaise—Methotrexate—bone cancer	0.000178	0.00161	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—bone cancer	0.000178	0.00161	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	0.000177	0.00249	CbGpPWpGaD
Ketoprofen—Chills—Doxorubicin—bone cancer	0.000176	0.0016	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—bone cancer	0.000176	0.00159	CcSEcCtD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000175	0.00247	CbGpPWpGaD
Ketoprofen—Nausea—Cisplatin—bone cancer	0.000175	0.00158	CcSEcCtD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000174	0.00246	CbGpPWpGaD
Ketoprofen—Alopecia—Doxorubicin—bone cancer	0.000174	0.00157	CcSEcCtD
Ketoprofen—CXCL8—Metabolism of proteins—TUBB4B—bone cancer	0.000172	0.00242	CbGpPWpGaD
Ketoprofen—Ill-defined disorder—Epirubicin—bone cancer	0.000172	0.00155	CcSEcCtD
Ketoprofen—Convulsion—Methotrexate—bone cancer	0.000171	0.00155	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—bone cancer	0.000171	0.00155	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—bone cancer	0.000171	0.00155	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—EGFR—bone cancer	0.000171	0.00241	CbGpPWpGaD
Ketoprofen—Flatulence—Doxorubicin—bone cancer	0.000169	0.00153	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—MDM2—bone cancer	0.000168	0.00237	CbGpPWpGaD
Ketoprofen—Myalgia—Methotrexate—bone cancer	0.000168	0.00152	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—bone cancer	0.000168	0.00152	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—bone cancer	0.000168	0.00152	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000167	0.00236	CbGpPWpGaD
Ketoprofen—Malaise—Epirubicin—bone cancer	0.000167	0.00151	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—bone cancer	0.000166	0.0015	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—bone cancer	0.000166	0.0015	CcSEcCtD
Ketoprofen—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000166	0.00234	CbGpPWpGaD
Ketoprofen—Vertigo—Epirubicin—bone cancer	0.000166	0.0015	CcSEcCtD
Ketoprofen—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000166	0.00233	CbGpPWpGaD
Ketoprofen—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000164	0.00231	CbGpPWpGaD
Ketoprofen—Palpitations—Epirubicin—bone cancer	0.000163	0.00148	CcSEcCtD
Ketoprofen—Confusional state—Methotrexate—bone cancer	0.000163	0.00147	CcSEcCtD
Ketoprofen—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000162	0.00228	CbGpPWpGaD
Ketoprofen—Anaphylactic shock—Methotrexate—bone cancer	0.000161	0.00146	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—GNA11—bone cancer	0.000161	0.00227	CbGpPWpGaD
Ketoprofen—Convulsion—Epirubicin—bone cancer	0.00016	0.00145	CcSEcCtD
Ketoprofen—Infection—Methotrexate—bone cancer	0.00016	0.00145	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—bone cancer	0.00016	0.00145	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—SMO—bone cancer	0.00016	0.00225	CbGpPWpGaD
Ketoprofen—Ill-defined disorder—Doxorubicin—bone cancer	0.000159	0.00144	CcSEcCtD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000159	0.00224	CbGpPWpGaD
Ketoprofen—Anaemia—Doxorubicin—bone cancer	0.000158	0.00143	CcSEcCtD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000158	0.00223	CbGpPWpGaD
Ketoprofen—Thrombocytopenia—Methotrexate—bone cancer	0.000158	0.00143	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—bone cancer	0.000157	0.00142	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—bone cancer	0.000157	0.00142	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—bone cancer	0.000156	0.00141	CcSEcCtD
Ketoprofen—Discomfort—Epirubicin—bone cancer	0.000156	0.00141	CcSEcCtD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000155	0.00218	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GRM4—bone cancer	0.000154	0.00218	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—RGS1—bone cancer	0.000154	0.00218	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000154	0.00218	CbGpPWpGaD
Ketoprofen—Malaise—Doxorubicin—bone cancer	0.000154	0.0014	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—bone cancer	0.000154	0.00139	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—bone cancer	0.000154	0.00139	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—bone cancer	0.000154	0.00139	CcSEcCtD
Ketoprofen—Confusional state—Epirubicin—bone cancer	0.000152	0.00138	CcSEcCtD
Ketoprofen—Flurbiprofen—PTGS2—bone cancer	0.000152	0.019	CrCbGaD
Ketoprofen—Palpitations—Doxorubicin—bone cancer	0.000151	0.00137	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—bone cancer	0.000151	0.00137	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—bone cancer	0.000151	0.00137	CcSEcCtD
Ketoprofen—Infection—Epirubicin—bone cancer	0.00015	0.00136	CcSEcCtD
Ketoprofen—CXCL8—Cellular responses to stress—GSTP1—bone cancer	0.00015	0.00211	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—JUN—bone cancer	0.00015	0.00211	CbGpPWpGaD
Ketoprofen—Modafinil—CYP3A4—bone cancer	0.000149	0.0187	CrCbGaD
Ketoprofen—Shock—Epirubicin—bone cancer	0.000149	0.00134	CcSEcCtD
Ketoprofen—CXCL8—Metabolism of proteins—TUBB2A—bone cancer	0.000148	0.00209	CbGpPWpGaD
Ketoprofen—Convulsion—Doxorubicin—bone cancer	0.000148	0.00134	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000148	0.00209	CbGpPWpGaD
Ketoprofen—Thrombocytopenia—Epirubicin—bone cancer	0.000148	0.00134	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—PTGS2—bone cancer	0.000148	0.00208	CbGpPWpGaD
Ketoprofen—Hypertension—Doxorubicin—bone cancer	0.000148	0.00134	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—bone cancer	0.000147	0.00133	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000147	0.00133	CcSEcCtD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—JUN—bone cancer	0.000146	0.00206	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—JUN—bone cancer	0.000146	0.00206	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—GNA11—bone cancer	0.000146	0.00206	CbGpPWpGaD
Ketoprofen—Hyperhidrosis—Epirubicin—bone cancer	0.000146	0.00132	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—bone cancer	0.000146	0.00132	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—IL3—bone cancer	0.000146	0.00205	CbGpPWpGaD
Ketoprofen—Myalgia—Doxorubicin—bone cancer	0.000146	0.00132	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—bone cancer	0.000145	0.00131	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—bone cancer	0.000145	0.00131	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—bone cancer	0.000144	0.0013	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—bone cancer	0.000144	0.0013	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—bone cancer	0.000144	0.0013	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—CDK4—bone cancer	0.000144	0.00203	CbGpPWpGaD
Ketoprofen—Somnolence—Methotrexate—bone cancer	0.000143	0.0013	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—bone cancer	0.000142	0.00129	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—bone cancer	0.000142	0.00128	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000141	0.00199	CbGpPWpGaD
Ketoprofen—Confusional state—Doxorubicin—bone cancer	0.000141	0.00127	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—SMO—bone cancer	0.00014	0.00198	CbGpPWpGaD
Ketoprofen—Decreased appetite—Methotrexate—bone cancer	0.00014	0.00127	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—bone cancer	0.00014	0.00126	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—bone cancer	0.00014	0.00126	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—bone cancer	0.000139	0.00126	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—bone cancer	0.000139	0.00126	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—bone cancer	0.000139	0.00126	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000138	0.00124	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—bone cancer	0.000137	0.00124	CcSEcCtD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000137	0.00193	CbGpPWpGaD
Ketoprofen—Thrombocytopenia—Doxorubicin—bone cancer	0.000137	0.00124	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—bone cancer	0.000137	0.00124	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—bone cancer	0.000136	0.00123	CcSEcCtD
Ketoprofen—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000136	0.00192	CbGpPWpGaD
Ketoprofen—Paraesthesia—Epirubicin—bone cancer	0.000136	0.00123	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—bone cancer	0.000135	0.00122	CcSEcCtD
Ketoprofen—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000135	0.0019	CbGpPWpGaD
Ketoprofen—Dyspnoea—Epirubicin—bone cancer	0.000135	0.00122	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—bone cancer	0.000134	0.00121	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—GRM1—bone cancer	0.000134	0.00189	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TP53—bone cancer	0.000134	0.00188	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000133	0.00188	CbGpPWpGaD
Ketoprofen—Anorexia—Doxorubicin—bone cancer	0.000133	0.0012	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—bone cancer	0.000133	0.0012	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—bone cancer	0.000133	0.0012	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—IL3—bone cancer	0.000132	0.00187	CbGpPWpGaD
Ketoprofen—Gastrointestinal pain—Methotrexate—bone cancer	0.000132	0.00119	CcSEcCtD
Ketoprofen—Decreased appetite—Epirubicin—bone cancer	0.000131	0.00119	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—bone cancer	0.00013	0.00118	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—bone cancer	0.00013	0.00118	CcSEcCtD
Ketoprofen—CXCL8—GPCR downstream signaling—GRM4—bone cancer	0.00013	0.00183	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—RGS1—bone cancer	0.00013	0.00183	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—MMP9—bone cancer	0.00013	0.00183	CbGpPWpGaD
Ketoprofen—Constipation—Epirubicin—bone cancer	0.000129	0.00117	CcSEcCtD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000129	0.00182	CbGpPWpGaD
Ketoprofen—Atomoxetine—CYP3A4—bone cancer	0.000128	0.016	CrCbGaD
Ketoprofen—Urticaria—Methotrexate—bone cancer	0.000128	0.00116	CcSEcCtD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000128	0.0018	CbGpPWpGaD
Ketoprofen—Abdominal pain—Methotrexate—bone cancer	0.000128	0.00115	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000127	0.00115	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—bone cancer	0.000126	0.00114	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—bone cancer	0.000125	0.00113	CcSEcCtD
Ketoprofen—CXCL8—Cellular Senescence—RB1—bone cancer	0.000125	0.00176	CbGpPWpGaD
Ketoprofen—Dyspnoea—Doxorubicin—bone cancer	0.000125	0.00113	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—bone cancer	0.000124	0.00113	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—bone cancer	0.000124	0.00112	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—bone cancer	0.000123	0.00112	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—bone cancer	0.000123	0.00111	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—bone cancer	0.000121	0.0011	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000121	0.00109	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—bone cancer	0.00012	0.00109	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—bone cancer	0.00012	0.00109	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00012	0.00169	CbGpPWpGaD
Ketoprofen—Constipation—Doxorubicin—bone cancer	0.000119	0.00108	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—bone cancer	0.000119	0.00108	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—bone cancer	0.000119	0.00108	CcSEcCtD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000118	0.00167	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—RGS1—bone cancer	0.000118	0.00166	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GRM4—bone cancer	0.000118	0.00166	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—bone cancer	0.000118	0.00166	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	0.000117	0.00165	CbGpPWpGaD
Ketoprofen—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000116	0.00164	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000116	0.00164	CbGpPWpGaD
Ketoprofen—Asthenia—Methotrexate—bone cancer	0.000116	0.00105	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—bone cancer	0.000115	0.00104	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—bone cancer	0.000114	0.00103	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—bone cancer	0.000114	0.00103	CcSEcCtD
Ketoprofen—CXCL8—GPCR downstream signaling—GRM1—bone cancer	0.000113	0.00159	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—KIT—bone cancer	0.000112	0.00158	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000111	0.00157	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Epirubicin—bone cancer	0.000111	0.00101	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—bone cancer	0.000111	0.001	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—bone cancer	0.00011	0.000999	CcSEcCtD
Ketoprofen—Diarrhoea—Methotrexate—bone cancer	0.00011	0.000999	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000109	0.00154	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—CDK4—bone cancer	0.000109	0.00153	CbGpPWpGaD
Ketoprofen—Asthenia—Epirubicin—bone cancer	0.000108	0.00098	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.000107	0.00151	CbGpPWpGaD
Ketoprofen—Pruritus—Epirubicin—bone cancer	0.000107	0.000966	CcSEcCtD
Ketoprofen—Dizziness—Methotrexate—bone cancer	0.000107	0.000965	CcSEcCtD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—JUN—bone cancer	0.000107	0.0015	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—MDM2—bone cancer	0.000107	0.0015	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—EGFR—bone cancer	0.000105	0.00148	CbGpPWpGaD
Ketoprofen—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000105	0.00148	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—EIF2S1—bone cancer	0.000103	0.00146	CbGpPWpGaD
Ketoprofen—Diarrhoea—Epirubicin—bone cancer	0.000103	0.000935	CcSEcCtD
Ketoprofen—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000103	0.00145	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Doxorubicin—bone cancer	0.000103	0.000931	CcSEcCtD
Ketoprofen—Vomiting—Methotrexate—bone cancer	0.000103	0.000928	CcSEcCtD
Ketoprofen—CXCL8—Signaling by GPCR—GRM1—bone cancer	0.000102	0.00144	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000102	0.00144	CbGpPWpGaD
Ketoprofen—Rash—Methotrexate—bone cancer	0.000102	0.00092	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—bone cancer	0.000102	0.00092	CcSEcCtD
Ketoprofen—Headache—Methotrexate—bone cancer	0.000101	0.000914	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—bone cancer	0.0001	0.000907	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—bone cancer	9.98e-05	0.000903	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.94e-05	0.0014	CbGpPWpGaD
Ketoprofen—Pruritus—Doxorubicin—bone cancer	9.88e-05	0.000894	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—SPARC—bone cancer	9.83e-05	0.00139	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.8e-05	0.00138	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	9.75e-05	0.00137	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—bone cancer	9.66e-05	0.00136	CbGpPWpGaD
Ketoprofen—Vomiting—Epirubicin—bone cancer	9.6e-05	0.000869	CcSEcCtD
Ketoprofen—Nausea—Methotrexate—bone cancer	9.58e-05	0.000867	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—bone cancer	9.56e-05	0.000865	CcSEcCtD
Ketoprofen—Rash—Epirubicin—bone cancer	9.52e-05	0.000861	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—bone cancer	9.51e-05	0.000861	CcSEcCtD
Ketoprofen—Headache—Epirubicin—bone cancer	9.46e-05	0.000856	CcSEcCtD
Ketoprofen—CXCL8—Cellular responses to stress—RB1—bone cancer	9.44e-05	0.00133	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SMO—bone cancer	9.43e-05	0.00133	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—JUN—bone cancer	9.26e-05	0.00131	CbGpPWpGaD
Ketoprofen—Dizziness—Doxorubicin—bone cancer	9.24e-05	0.000836	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—CDK4—bone cancer	9.06e-05	0.00128	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—GNA11—bone cancer	8.99e-05	0.00127	CbGpPWpGaD
Ketoprofen—Nausea—Epirubicin—bone cancer	8.97e-05	0.000811	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism—NT5C3A—bone cancer	8.89e-05	0.00125	CbGpPWpGaD
Ketoprofen—Vomiting—Doxorubicin—bone cancer	8.88e-05	0.000804	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—bone cancer	8.81e-05	0.000797	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—bone cancer	8.8e-05	0.000796	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—bone cancer	8.8e-05	0.00124	CbGpPWpGaD
Ketoprofen—CYP2C8—Biological oxidations—CYP3A4—bone cancer	8.79e-05	0.00124	CbGpPWpGaD
Ketoprofen—Headache—Doxorubicin—bone cancer	8.75e-05	0.000792	CcSEcCtD
Ketoprofen—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	8.67e-05	0.00122	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	8.63e-05	0.00122	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GNA11—bone cancer	8.62e-05	0.00122	CbGpPWpGaD
Ketoprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.52e-05	0.0012	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.31e-05	0.00117	CbGpPWpGaD
Ketoprofen—Nausea—Doxorubicin—bone cancer	8.3e-05	0.000751	CcSEcCtD
Ketoprofen—PTGS1—Metabolism—NDUFA12—bone cancer	8.16e-05	0.00115	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IL3—bone cancer	8.15e-05	0.00115	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—MDM2—bone cancer	8.05e-05	0.00113	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ATF1—bone cancer	8.02e-05	0.00113	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	7.89e-05	0.00111	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—RB1—bone cancer	7.88e-05	0.00111	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL3—bone cancer	7.82e-05	0.0011	CbGpPWpGaD
Ketoprofen—CYP2C8—Biological oxidations—GSTP1—bone cancer	7.52e-05	0.00106	CbGpPWpGaD
Ketoprofen—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	7.42e-05	0.00105	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—GNA11—bone cancer	7.25e-05	0.00102	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—SMO—bone cancer	7.2e-05	0.00102	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—CYP3A4—bone cancer	7.16e-05	0.00101	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	7.16e-05	0.00101	CbGpPWpGaD
Ketoprofen—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	7.06e-05	0.000995	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—JUN—bone cancer	7e-05	0.000986	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RGS1—bone cancer	6.97e-05	0.000982	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GRM4—bone cancer	6.97e-05	0.000982	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NT5C3A—bone cancer	6.76e-05	0.000953	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.7e-05	0.000945	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TGFBR2—bone cancer	6.69e-05	0.000942	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	6.62e-05	0.000934	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GNA11—bone cancer	6.59e-05	0.000929	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—IL3—bone cancer	6.58e-05	0.000927	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NDUFA12—bone cancer	6.48e-05	0.000913	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IGF1R—bone cancer	6.29e-05	0.000887	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.16e-05	0.000869	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—GSTP1—bone cancer	6.12e-05	0.000863	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—bone cancer	6.11e-05	0.000861	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GRM1—bone cancer	6.04e-05	0.000851	CbGpPWpGaD
Ketoprofen—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	6.04e-05	0.000851	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL3—bone cancer	5.97e-05	0.000842	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.79e-05	0.000816	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MMP9—bone cancer	5.68e-05	0.0008	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NT5C3A—bone cancer	5.37e-05	0.000757	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PLAU—bone cancer	5.35e-05	0.000754	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NDUFA12—bone cancer	5.27e-05	0.000743	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NDUFA12—bone cancer	5.24e-05	0.000739	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—bone cancer	4.96e-05	0.000699	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—bone cancer	4.62e-05	0.000651	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—EGFR—bone cancer	4.59e-05	0.000647	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.57e-05	0.000644	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KIT—bone cancer	4.56e-05	0.000643	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SPARC—bone cancer	4.45e-05	0.000627	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NT5C3A—bone cancer	4.37e-05	0.000616	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NT5C3A—bone cancer	4.34e-05	0.000612	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NDUFA12—bone cancer	4.29e-05	0.000605	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—BRAF—bone cancer	4.29e-05	0.000604	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SMO—bone cancer	4.26e-05	0.0006	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP2—bone cancer	4.23e-05	0.000597	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—EGFR—bone cancer	4.16e-05	0.000586	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—GNA11—bone cancer	4.07e-05	0.000573	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.97e-05	0.00056	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ENO2—bone cancer	3.89e-05	0.000549	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GNA11—bone cancer	3.89e-05	0.000549	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—bone cancer	3.85e-05	0.000543	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL3—bone cancer	3.69e-05	0.00052	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ATF1—bone cancer	3.62e-05	0.00051	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—DHFR—bone cancer	3.61e-05	0.000509	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MDM2—bone cancer	3.59e-05	0.000506	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NT5C3A—bone cancer	3.56e-05	0.000501	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL3—bone cancer	3.53e-05	0.000497	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNA11—bone cancer	3.38e-05	0.000476	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—JUN—bone cancer	3.12e-05	0.00044	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.12e-05	0.00044	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CYP3A4—bone cancer	3.06e-05	0.000431	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.05e-05	0.000429	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—bone cancer	3.04e-05	0.000428	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFBR2—bone cancer	3.02e-05	0.000425	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ENO2—bone cancer	2.96e-05	0.000418	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1R—bone cancer	2.84e-05	0.0004	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ENO2—bone cancer	2.81e-05	0.000396	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—DHFR—bone cancer	2.75e-05	0.000387	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.62e-05	0.000369	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSTP1—bone cancer	2.62e-05	0.000369	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—DHFR—bone cancer	2.6e-05	0.000367	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNA11—bone cancer	2.57e-05	0.000362	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—bone cancer	2.46e-05	0.000346	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PLAU—bone cancer	2.42e-05	0.000341	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ENO2—bone cancer	2.35e-05	0.000331	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CYP3A4—bone cancer	2.33e-05	0.000328	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.32e-05	0.000327	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—DHFR—bone cancer	2.18e-05	0.000307	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—bone cancer	2.15e-05	0.000303	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—bone cancer	2.06e-05	0.000291	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KIT—bone cancer	2.06e-05	0.00029	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNA11—bone cancer	2.04e-05	0.000287	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTP1—bone cancer	1.99e-05	0.000281	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—BRAF—bone cancer	1.94e-05	0.000273	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ENO2—bone cancer	1.91e-05	0.00027	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ENO2—bone cancer	1.9e-05	0.000268	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFBR2—bone cancer	1.89e-05	0.000266	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—bone cancer	1.88e-05	0.000264	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CYP3A4—bone cancer	1.85e-05	0.000261	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—DHFR—bone cancer	1.78e-05	0.00025	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—DHFR—bone cancer	1.76e-05	0.000249	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNA11—bone cancer	1.66e-05	0.000234	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNA11—bone cancer	1.65e-05	0.000232	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MDM2—bone cancer	1.62e-05	0.000229	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTP1—bone cancer	1.58e-05	0.000223	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ENO2—bone cancer	1.56e-05	0.000219	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000212	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.5e-05	0.000211	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP3A4—bone cancer	1.5e-05	0.000211	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.49e-05	0.00021	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—DHFR—bone cancer	1.44e-05	0.000204	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—JUN—bone cancer	1.41e-05	0.000199	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—bone cancer	1.37e-05	0.000193	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—bone cancer	1.36e-05	0.000191	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNA11—bone cancer	1.35e-05	0.00019	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KIT—bone cancer	1.29e-05	0.000182	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTP1—bone cancer	1.29e-05	0.000181	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTP1—bone cancer	1.28e-05	0.00018	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP3A4—bone cancer	1.22e-05	0.000173	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.22e-05	0.000172	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—BRAF—bone cancer	1.21e-05	0.000171	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—bone cancer	1.11e-05	0.000156	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTP1—bone cancer	1.05e-05	0.000148	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—bone cancer	1.03e-05	0.000145	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MDM2—bone cancer	1.01e-05	0.000143	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—bone cancer	9.73e-06	0.000137	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—bone cancer	9.3e-06	0.000131	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—bone cancer	6.93e-06	9.77e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—bone cancer	6.66e-06	9.39e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—bone cancer	6.63e-06	9.34e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—bone cancer	5.42e-06	7.64e-05	CbGpPWpGaD
